Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

LEUKEMIA INHIBITORY FACTOR MESSENGER-RNA IS EXPRESSED IN CORTICAL ASTROCYTE CULTURES BUT NOT IN AN IMMORTALIZED MICROGLIAL CELL-LINE NEUROSCIENCE LETTERS Murphy, G. M., Song, Y. L., Ong, E., Lee, Y. L., Schmidt, K. G., Bocchini, V., Eng, L. F. 1995; 184 (1): 48-51

Abstract

Leukemia inhibitory factor (LIF) is a multifunctional cytokine synthesized by a variety of cell types. In the nervous system LIF affects neuronal differentiation, and may be important during cerebral infection and inflammation. To clarify the cellular source of LIF in the brain, we examined the expression of LIF mRNA by primary cortical astrocyte cultures and an immortalized microglial cell line. The microglial cell line did not express LIF mRNA in response to pro-inflammatory agents such as lipopolysaccharide (LPS) that induced expression of other cytokine mRNAs. In contrast, primary astrocyte cultures grown in serum-containing medium expressed LIF mRNA constitutively, and this expression was regulated by pro-inflammatory and anti-inflammatory stimuli. Agents which activate the cAMP and protein kinase C second messenger systems also increased LIF mRNA in astrocyte cultures. These results suggest that astrocytes, but not microglia, may be an important source of LIF during cerebral inflammation and infection.

View details for Web of Science ID A1995QD59100013

View details for PubMedID 7739804